Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios A Margonis

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 19, 2016
Conditional probability of long-term survival after resection of hilar cholangiocarcinomaStefan Buettner, Georgios A Margonis, Yuhree Kim, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 14, 2019
KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver MetastasesGeorgios A Margonis, Neda Amini, Nikolaos Andreatos, et al.
JAMA Surgery|May 11, 2022
Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic CholangiocarcinomaStijn Franssen, Kevin C Soares, Joshua Samuel Jolissaint, et al.
The British Journal of Surgery|May 20, 2022
KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutationsPim B Olthof, Stefan Buettner, Nikolaos Andreatos, et al.
JAMA Surgery|December 18, 2015
Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical CarcinomaYuhree Kim, Georgios A Margonis, Jason D Prescott, et al.
Annals of Surgery|December 24, 2016
Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free ProbabilityYuhree Kim, Georgios A Margonis, Jason D Prescott, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 20, 2015
Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical CarcinomaJavier Valero-Elizondo, Yuhree Kim, Jason D Prescott, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 28, 2017
Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastasesStefan Buettner, Jeroen L A van Vugt, Marcia P Gaspersz, et al.
Annals of Surgery|December 1, 2022
Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical QuestionsGeorgios A Margonis, Thomas Boerner, Jean-Baptiste Bachet, et al.
Journal of the National Cancer Institute|May 16, 2019
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-AnalysisQuisette P Janssen, Stefan Buettner, Mustafa Suker, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 19, 2016
Conditional probability of long-term survival after resection of hilar cholangiocarcinomaStefan Buettner, Georgios A Margonis, Yuhree Kim, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 14, 2019
KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver MetastasesGeorgios A Margonis, Neda Amini, Nikolaos Andreatos, et al.
JAMA Surgery|May 11, 2022
Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic CholangiocarcinomaStijn Franssen, Kevin C Soares, Joshua Samuel Jolissaint, et al.
The British Journal of Surgery|May 20, 2022
KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutationsPim B Olthof, Stefan Buettner, Nikolaos Andreatos, et al.
JAMA Surgery|December 18, 2015
Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical CarcinomaYuhree Kim, Georgios A Margonis, Jason D Prescott, et al.
Annals of Surgery|December 24, 2016
Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free ProbabilityYuhree Kim, Georgios A Margonis, Jason D Prescott, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 20, 2015
Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical CarcinomaJavier Valero-Elizondo, Yuhree Kim, Jason D Prescott, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 28, 2017
Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastasesStefan Buettner, Jeroen L A van Vugt, Marcia P Gaspersz, et al.
Annals of Surgery|December 1, 2022
Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical QuestionsGeorgios A Margonis, Thomas Boerner, Jean-Baptiste Bachet, et al.
Journal of the National Cancer Institute|May 16, 2019
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-AnalysisQuisette P Janssen, Stefan Buettner, Mustafa Suker, et al.
Pageof 7